A Phase 1/1b Study of IAM1363 in HER2 Cancers

Conditions: Cancers Harboring HER2 Alterations Interventions: Drug: IAM1363; Drug: Trastuzumab Sponsors: Iambic Therapeutics, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials